CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-11 | Stuglik Brian M Director | Grant or award · Stock Option (right to buy) | +11,865 | 11,865 | ||
| 2024-03-11 | Rowinsky Eric K Director | Returned to the company · Stock Option (right to buy) | −4,166 | 0 | ||
| 2024-03-11 | Rowinsky Eric K Director | Returned to the company · Stock Option (right to buy) | −2,157 | 0 | ||
| 2024-03-11 | Rowinsky Eric K Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 | ||
| 2024-03-11 | Rowinsky Eric K Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 | ||
| 2024-03-11 | Rowinsky Eric K Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 | ||
| 2024-03-11 | Rowinsky Eric K Director | Grant or award · Stock Option (right to buy) | +12,572 | 12,572 | ||
| 2024-03-11 | JOHNSON JOHN Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 | ||
| 2024-03-11 | JOHNSON JOHN Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 | ||
| 2024-03-11 | JOHNSON JOHN Director | Returned to the company · Stock Option (right to buy) | −2,300 | 0 | ||
| 2024-03-11 | JOHNSON JOHN Director | Returned to the company · Stock Option (right to buy) | −2,083 | 0 | ||
| 2024-03-11 | JOHNSON JOHN Director | Grant or award · Stock Option (right to buy) | +8,549 | 8,549 | ||
| 2024-03-11 | Paterson Dan President and CEO | Returned to the company · Stock Option (right to buy) | −12,064 | 0 | ||
| 2024-03-11 | Paterson Dan President and CEO | Returned to the company · Stock Option (right to buy) | −11,166 | 0 | ||
| 2024-03-11 | Paterson Dan President and CEO | Returned to the company · Stock Option (right to buy) | −5,500 | 0 | ||
| 2024-03-11 | Paterson Dan President and CEO | Returned to the company · Stock Option (right to buy) | −8,333 | 0 | ||
| 2024-03-11 | Paterson Dan President and CEO | Returned to the company · Stock Option (right to buy) | −6,249 | 0 | ||
| 2024-03-11 | Paterson Dan President and CEO | Returned to the company · Stock Option (right to buy) | −3,750 | 0 | ||
| 2024-03-11 | Paterson Dan President and CEO | Returned to the company · Stock Option (right to buy) | −6,250 | 0 | ||
| 2024-03-11 | Paterson Dan President and CEO | Returned to the company · Stock Option (right to buy) | −20,832 | 0 |
Page 9 of 17 · 326 trades